CINECA IRIS Institutional Research Information System

LANZOLLA, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.762
AS - Asia 1.163
EU - Europa 803
SA - Sud America 198
AF - Africa 57
OC - Oceania 1
Totale 3.984
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.734
SG - Singapore 459
CN - Cina 267
HK - Hong Kong 201
SE - Svezia 182
IT - Italia 180
BR - Brasile 167
DE - Germania 127
VN - Vietnam 73
FR - Francia 60
GB - Regno Unito 55
BG - Bulgaria 46
AT - Austria 37
IN - India 34
FI - Finlandia 33
JP - Giappone 32
TR - Turchia 25
RU - Federazione Russa 24
CI - Costa d'Avorio 20
SN - Senegal 14
BD - Bangladesh 13
IQ - Iraq 13
CA - Canada 12
ZA - Sudafrica 12
UA - Ucraina 10
SA - Arabia Saudita 9
ES - Italia 8
NL - Olanda 8
PL - Polonia 8
AR - Argentina 7
MX - Messico 7
UZ - Uzbekistan 6
VE - Venezuela 6
CO - Colombia 5
BE - Belgio 4
EG - Egitto 4
IE - Irlanda 4
JO - Giordania 4
PY - Paraguay 4
AZ - Azerbaigian 3
EC - Ecuador 3
MA - Marocco 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
ID - Indonesia 2
IR - Iran 2
LB - Libano 2
LT - Lituania 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
TW - Taiwan 2
UY - Uruguay 2
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
Totale 3.984
Salva come PNG Salva come JPEG
Città #
Dallas 371
Singapore 241
Ashburn 219
Hong Kong 199
Santa Clara 122
Chandler 107
San Jose 90
Fairfield 85
Shanghai 68
Beijing 66
New York 57
Munich 55
Los Angeles 48
Sofia 46
Seattle 43
Woodbridge 42
Boardman 38
Florence 38
Wilmington 36
Vienna 31
Houston 29
London 28
Turku 27
Bremen 24
Frankfurt am Main 23
Marseille 23
Tokyo 23
Ho Chi Minh City 21
Abidjan 20
Lawrence 20
Princeton 20
Rome 19
Pisa 17
Cambridge 16
Istanbul 16
Hanoi 15
Medford 15
Chicago 14
Dakar 14
Atlanta 13
Ann Arbor 12
Redondo Beach 12
Denver 11
Düsseldorf 11
Lucca 11
Brooklyn 9
Buffalo 9
San Diego 9
São Paulo 9
Vicopisano 9
Chennai 8
Johannesburg 8
Ogden 8
Baghdad 7
Dong Ket 7
Poplar 7
Boston 6
Cagliari 6
Fuzhou 6
Nuremberg 6
Amsterdam 5
Cascina 5
Guangzhou 5
Helsinki 5
Livorno 5
Mexico City 5
Milan 5
Orem 5
Paris 5
Rio de Janeiro 5
San Francisco 5
Serra 5
Warsaw 5
Zhengzhou 5
Amman 4
Ankara 4
Belo Horizonte 4
Brussels 4
Caracas 4
Elk Grove Village 4
Jeddah 4
Manchester 4
Miami 4
Montreal 4
Norwalk 4
Ossé 4
Quanzhou 4
Tashkent 4
Baku 3
Basra 3
Campinas 3
Canoas 3
Da Nang 3
Des Moines 3
Dhaka 3
Dublin 3
Genoa 3
Ha Long 3
João Pessoa 3
Juiz de Fora 3
Totale 2.732
Salva come PNG Salva come JPEG
Nome #
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 175
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 166
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases 160
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study 159
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy 155
Orbital diseases mimicking graves’ orbitopathy: a long-standing challenge in differential diagnosis 140
Immune Checkpoint Blockade Anti-PD-L1 as a Trigger for Autoimmune Polyendocrine Syndrome 135
null 120
Functional outcomes and complications in refractory dysthyroid optic neuropathy management: Experience with 3 different surgical protocols 119
In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' orbitopathy 114
Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease 103
Occurrence of Graves’ hyperthyroidism and Graves’ orbitopathy after fine-needle aspiration biopsy of thyroid nodules 102
Sirolimus as a second-line treatment for Graves' orbitopathy 92
Genetic profiling of orbital fibroblasts from patients with Graves' orbitopathy 86
null 85
Beneficial effect of low-dose radioiodine ablation for Graves' orbitopathy: results of a retrospective study 83
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 81
null 80
Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study 78
IgG4 serum levels in Graves' orbitopathy 77
null 77
Long-term outcome of Graves’ orbitopathy following treatment with sirolimus 76
Ocular surface disease index in Graves’ orbitopathy: a cross-sectional study 76
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment 75
Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III) 73
Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort Study 72
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy 71
Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy 71
null 68
Insights Into the Role of DNA Methylation and Gene Expression in Graves Orbitopathy 66
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 65
Antioxidant Therapy in Graves’ Orbitopathy 62
Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study 61
Insights Into the Role of DNA Methylation and Gene Expression in Graves Orbitopathy 61
Absence of a relationship between vitamin D and Graves’ orbitopathy 59
IgG4 serum levels in Graves' orbitopathy 57
null 57
Graves disease: latest understanding of pathogenesis and treatment options 56
Genetic Profiling of Orbital Fibroblasts from Patients with Graves’ Orbitopathy 55
Absence of a relationship between vitamin D and Graves’ orbitopathy 49
Statins in Graves Orbitopathy: A New Therapeutic Tool 47
Statins in Graves Orbitopathy: A New Therapeutic Tool 46
Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy 44
null 43
null 37
null 35
Graves’ disease and Graves’ orbitopathy following COVID-19 31
null 30
Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy 28
Statins: A New Hope on the Horizon of Graves Orbitopathy? 26
Oxidative Stress in Graves Disease and Graves Orbitopathy 24
Oxidative Stress in Graves Disease and Graves Orbitopathy 15
Statins: A New Hope on the Horizon of Graves Orbitopathy? 15
Risk of Neck Hematoma Following Thyroidectomy in Patients Taking Direct Oral Anticoagulants: A Propensity Score Matching Analysis from Nine High-Volume European Centers (RAGNO Study) 7
null 3
null 1
null 1
null 1
Totale 4.051
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.202
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202198 0 0 0 0 0 0 17 9 19 13 22 18
2021/2022284 0 2 1 25 60 38 7 8 40 47 12 44
2022/2023470 48 77 49 36 36 48 2 30 92 5 43 4
2023/2024200 4 18 17 14 18 45 17 7 2 4 30 24
2024/20251.276 11 33 22 45 98 143 110 56 129 134 158 337
2025/20261.480 154 262 362 216 224 136 126 0 0 0 0 0
Totale 4.051